Skip to main content
SpringerLink
Log in

The involvement of oncogenes and tumor suppressor genes in the control of apoptosis

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Arends MJ, Wyllie AH: Apoptosis: mechanisms and role in pathology. Int Rev Exp Pathol 32: 223–256, 1991

    Google Scholar 

  2. Williams GT: Programmed cell death: apoptosis and oncogenesis. Cell 65: 1097–1098, 1991

    Google Scholar 

  3. Collins M: Death by a thousand cuts. Curr Biol 1: 140–142, 1991

    Google Scholar 

  4. Golstein P, Ojcius DM, Young JD-E: Cell death mechanisms and the immune system. Immunol Rev 121: 29–65, 1991

    Google Scholar 

  5. Ellis RE, Yuan J, Horvitz HR: Mechanisms and functions of cell death. Ann Rev Cell Biol 7: 663–698, 1991

    Google Scholar 

  6. Williams GT, Smith CA, Spooncer E, Dexter TM, Taylor DR: Hemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343: 76–79, 1990

    Google Scholar 

  7. Koury MJ, Bondurant MC: Erythropoietin retards DNA breakdown and prevents programmed cell death in erythroid progenitor cells. Science 248: 378–381, 1990

    Google Scholar 

  8. Liu Y-J, Joshua DE, Williams GT, Smith CA, Gordon J, MacLennan ICM: Mechanism of antigen-driven selection in germinal centres. Nature 342: 929–931, 1989

    Google Scholar 

  9. Schulte-Hermann R, Timmermann-Trosiener I, Barthel G, Bursch W: DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res 50: 5127–5135, 1990

    Google Scholar 

  10. Umansky S: The genetic program of cell death. Hypothesis and some applications: transformation, carcinogenesis, ageing. J Theor Biol 97: 591–602, 1982

    Google Scholar 

  11. McConkey DJ, Hartzell P, Jondal M, Orrenius S: Inhibition of DNA fragmentation in thymocytes and isolated thymocyte nuclei by agents that stimulate protein kinase C. J Biol Chem 264: 13399–13402, 1989

    Google Scholar 

  12. Lotem J, Cragoe EJ, Sachs L: Rescue from programmed cell death in leukemic and normal myeloid cells. Blood 78: 953–960, 1991

    Google Scholar 

  13. Bursch W, Paffe S, Putz B, Barthel G, Schulte-Hermann R: Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis 11: 847–853, 1990

    Google Scholar 

  14. Tsujimoto Y, Finger LR, Junis J, Nowell PC, Croce CM: Cloning of the chromosome breakpoint of neoplastic B-cells with the t(14: 18) chromosomal translocation. Science 226: 1097–1099, 1984

    Google Scholar 

  15. Reed JC, Tsujimoto Y, Alpers JD, Croce CM, Nowell PC: Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation. Science 236: 1295–1299, 1987

    Google Scholar 

  16. McDonnell TJ, Deane N, Platt FM, Nunez G, Jaeger U, McKearn JP, Korsmeyer SJ: bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57: 79–88, 1989

    Google Scholar 

  17. McDonnell TJ, Nunez G, Platt FM, Hockenbery D, London L, McKearn JP, Korsmeyer SJ: Deregulated bcl-2 immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population. Mol Cell Biol 10: 1901–1907, 1990

    Google Scholar 

  18. McDonnell TJ, Korsmeyer SJ: Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14: 18). Nature 349: 254–256, 1991

    Google Scholar 

  19. Strasser A, Harris AW, Bath ML, Cory S: Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348: 331–333, 1990

    Google Scholar 

  20. Vaux DL, Cory S, Adams JM: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440–442, 1988

    Google Scholar 

  21. Strasser A, Harris AW, Cory S: bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67: 889–899, 1991

    Google Scholar 

  22. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ: bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67: 879–888, 1991

    Google Scholar 

  23. Rodriguez-Tarduchy G, Collins M, Lopez-Rivas A: Regulation of apoptosis in interleukin-3-dependent hemopoietic cells by interleukin-3 and calcium ionophores. EMBO J 9: 2997–3002, 1990

    Google Scholar 

  24. Liu Y-J, Mason DY, Johnson GD, Abbot S, Gregory CD, Hardie DL, Gordon J, MacLennan ICM: Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol 21: 1905–1910, 1991

    Google Scholar 

  25. Hockenbery D, Zutter M, Hickey W, Nahm M, Korsmeyer SJ: BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88: 6961–6965, 1991

    Google Scholar 

  26. Magrath I: The pathogenesis of Burkitt's lymphoma. Adv Cancer Res 55: 133–269, 1990

    Google Scholar 

  27. Gregory CD, Dive C, Henderson S, Smith C, Williams GT, Gordon J, Rickinson AB: Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 349: 612–614, 1991

    Google Scholar 

  28. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickinson A: Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65: 1107–1115, 1991

    Google Scholar 

  29. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334–336, 1990

    Google Scholar 

  30. Wyllie AH, Rose KA, Morris RG, Steel CM, Foster E, Spandidos DA: Rodent fibroblast tumours expressing human myc and ras genes: Growth, metastasis and endogenous oncogene expression. Br J Cancer 56: 251–259, 1987

    Google Scholar 

  31. Weinberg RA: Tumor suppressor genes. Science 254: 1138–1146, 1991

    Google Scholar 

  32. Levine AJ, Momand J, Finlay C: The p53 tumour suppressor gene. Nature 351: 453–456, 1991

    Google Scholar 

  33. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 253: 49–91, 1991

    Google Scholar 

  34. Oren M: Role of p53 in neoplasia. In: Biochemical and Molecular Aspects of Selected Cancers (Pretlow TG, Pretlow TP, eds), Academic Press, New York, pp 373–391, 1991

    Google Scholar 

  35. Mercer WE, Shields MT, Amin M, Sauve GJ, Apella E, Romano JW, Ullrich SJ: Negative growth regulation in a glioblastoma cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci USA 87: 6166–6170, 1990

    Google Scholar 

  36. Michalovitz D, Halevy O, Oren M: Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62: 671–680, 1990

    Google Scholar 

  37. Baker SJ, Markowitz S, Fearon ER, Willson JKV, Vogelstein B: Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249: 912–915, 1990

    Google Scholar 

  38. Diller L, Kassel J, Nelson CE, Gryka MA, Litwak G, Gebhardt M, Bressac B, Ozturk M, Baker SJ, Vogelstein B, Friend SH: p53 functions as a cell cycle control protein in osteosarcomas. Mol Cell Biol 10: 5772–5781, 1990

    Google Scholar 

  39. Martinez J, Georgoff I, Martinez J, Levine AJ: Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev 5: 151–159, 1991

    Google Scholar 

  40. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M: Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352: 345–347, 1991

    Google Scholar 

  41. Eliyahu D, Michalovitz D, Eliyahu S, Pinhasi-Kimhi O, Oren M: Wild-type p53 can inhibit oncogene-mediated focus formation. Proc Natl Acad Sci USA 86: 8763–8767, 1989

    Google Scholar 

  42. Finlay CA, Hinds PW, Levine AJ: The p53 proto-oncogene can act as a suppressor of transformation. Cell 57: 1083–1093, 1989

    Google Scholar 

  43. Baker SJ, Markowitz S, Fearon ER, Willson JKV, Vogelstein B: Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249: 912–915, 1990

    Google Scholar 

  44. McConkey DJ, Orrenius S, Jondal M: Cellular Signalling in programmed cell death (apoptosis). Immunol Today 11: 120–121, 1990

    Google Scholar 

  45. Askew DS, Ashmun RA, Simmons BC, Cleveland JL: Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6: 1915–1922, 1991

    Google Scholar 

  46. Maltzman W, Czyzyk L: UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol Cell Biol 4: 1689–1694, 1984

    Google Scholar 

  47. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304–6311, 1991

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Chemical Immunology, The Weizmann Institute of Science, 76100, Rehovot, Israel

    Moshe Oren

Authors
  1. Moshe Oren
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oren, M. The involvement of oncogenes and tumor suppressor genes in the control of apoptosis. Cancer Metast Rev 11, 141–148 (1992). https://doi.org/10.1007/BF00048060

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00048060

Key words

Search

Navigation